Adaptive Signature Design- review of the biomarker guided adaptive phase –III controlled design

Type: Review

Publication Date: 2019-05-16

Citations: 13

DOI: https://doi.org/10.1016/j.conctc.2019.100378

Locations

  • PubMed Central - View
  • Contemporary Clinical Trials Communications - View
  • Europe PMC (PubMed Central) - View - PDF
  • DOAJ (DOAJ: Directory of Open Access Journals) - View
  • PubMed - View

Similar Works

Action Title Year Authors
+ Biomarker adaptive designs in clinical trials 2014 James J. Chen
Tzu‐Pin Lu
Dung‐Tsa Chen
Sue-Jane Wang
+ PDF Chat Subgroup identification for treatment selection in biomarker adaptive design 2015 Tzu‐Pin Lu
James J. Chen
+ PDF Chat Adaptive enrichment in biomarker-stratified clinical trial design 2013 Deepak Parashar
Jack Bowden
Colin Starr
Lorenz Wernisch
Adrian Mander
+ Properties of adaptive clinical trial signature design in the presence of gene and gene-treatment interaction 2017 A. Cambon
Kathy B. Baumgartner
Guy Brock
Nigel G. F. Cooper
David Wu
S. N.
+ Properties of adaptive clinical trial signature design in the presence of gene and gene-treatment interaction 2017 A. Cambon
Kathy B. Baumgartner
Guy Brock
Nigel Cooper
David Wu
S. N.
+ Properties Of Adaptive Clinical Trial Signature Design In The Presence Of Gene And Gene -Treatment Interaction 2017 A. Cambon
Kathy B. Baumgartner
Guy Brock
Nigel Cooper
David Wu
S N
+ Futility for subgroup analyses in the adaptive signature design 2017 Andrea Callegaro
+ Targeted Therapy Design 2011 Guosheng Yin
+ PDF Chat Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review 2016 Miranta Antoniou
Andrea Jorgensen
Ruwanthi Kolamunnage‐Dona
+ Omics-based clinical trial designs 2013 Marc Buyse
Stefan Michiels
+ Abstract IA4-2: Design of phase III clinical trials for predictive oncology 2010 Richard Simon
+ Novel Biomarker Guided Clinical Trial Designs 2019 Bo Huang
Jing Wang
Robert A. Beckman
Sandeep Menon
Weidong Zhang
+ PDF Chat Adaptive Clinical Trial Designs for Simultaneous Testing of Matched Diagnostics and Therapeutics 2011 Howard I. Scher
S Nasso
Eric H. Rubin
Richard H. Simon
+ Biomarkers, subgroup evaluation, and clinical trial design. 2012 Stuart G. Baker
Barnett S. Kramer
Daniel J. Sargent
Marco Bonetti
+ PDF Chat Review of Statistical Methods for Biomarker-Driven Clinical Trials 2019 Richard Simon
+ Latest Developments in “Adaptive Enrichment” Clinical Trial Designs in Oncology 2024 Yue Tu
Lindsay A. Renfro
+ Biomarker enrichment considerations in oncology early development single-arm studies 2017 Hong Tian
Kevin Liu
+ Phase 3 Oncology Trials of Personalized Medicines with Adaptive Subpopulation Selection 2018 Cong Chen
Wen Li
Xiaoyun Li
Robert A. Beckman
+ PDF Chat Clinical Trials for Personalized Medicine: Design and Data Analysis 2022 Shigeyuki Matsui
+ PDF Chat Adaptive Signature Design: An Adaptive Clinical Trial Design for Generating and Prospectively Testing A Gene Expression Signature for Sensitive Patients 2005 Boris Freidlin
Richard Simon